申请人:Alnylam Pharmaceuticals, Inc.
公开号:US20160101189A1
公开(公告)日:2016-04-14
The invention features compounds of formula V or XII:
In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.